1h-imidazo(4,5-b)pyridine has been researched along with Hyperglycemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, Y; Liang, G; Liu, Z; Qian, J; Wang, Y; Yang, L; Yang, X; Yin, S; Zhuang, F | 1 |
1 other study(ies) available for 1h-imidazo(4,5-b)pyridine and Hyperglycemia
Article | Year |
---|---|
The imidazopyridine derivative X22 prevents diabetic kidney dysfunction through inactivating NF-κB signaling.
Topics: Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Hyperglycemia; Hypoglycemic Agents; Imidazoles; Kidney; Kidney Function Tests; Kidney Tubules, Proximal; Mice, Inbred C57BL; Nephritis; NF-kappa B; Pyridines; Rats; Signal Transduction | 2020 |